U.S. Personal Products Stock News

NYSE:ATHM
NYSE:ATHMInteractive Media and Services

Autohome (NYSE:ATHM) Q1 Net Income Collapse Tests Bullish Margin Narratives

Q1 2026 earnings snapshot sets the stage for Autohome (NYSE:ATHM) Autohome (NYSE:ATHM) opened 2026 with Q1 revenue of C¥1,048.4 million and basic EPS of C¥0.38, alongside net income of C¥44.3 million, putting fresh numbers behind a stock currently trading at $17.30. Over the last few quarters, revenue has moved from C¥1,783.4 million in Q4 2024 to C¥1,453.8 million in Q1 2025 and then to C¥1,048.4 million in Q1 2026, while quarterly basic EPS has shifted from C¥2.51 to C¥2.86 and then to...
NYSE:SQM
NYSE:SQMChemicals

Is It Too Late To Consider Sociedad Química y Minera de Chile (NYSE:SQM) After 169% Surge?

Wondering if Sociedad Química y Minera de Chile at around US$84.05 is still offering value after a strong run, or if you are arriving late to the story. The stock has returned 6.0% over the past week, is down 6.0% over the past month, but is up 20.5% year to date and 169.1% over the last year, which can change how the market is thinking about its risk and reward profile. Recent coverage has focused on Sociedad Química y Minera de Chile as a key player in materials and lithium related themes,...
NYSE:A
NYSE:ALife Sciences

Agilent Technologies (A) Margin Gains Reinforce Bullish Recurring Revenue Narrative After Q2 2026 Results

Agilent Technologies (A) has just reported Q2 2026 results with revenue of US$1,835 million and basic EPS of US$1.20, alongside trailing twelve month revenue of US$7.2 billion and EPS of US$5.00 that sit against a one year earnings growth figure of 21.3%. Over recent quarters, revenue has ranged between US$1,668 million and US$1,861 million while quarterly EPS has moved between roughly US$0.75 and US$1.53, with net profit margin across the last year at 19.6% compared to 17.6% a year earlier...
NasdaqCM:MNTS
NasdaqCM:MNTSAerospace & Defense

A Look At Momentus (MNTS) Valuation After New US$25m Private Placement And Recent Share Price Surge

Momentus (MNTS) has drawn fresh attention after entering securities purchase agreements with existing institutional investors for a private placement of 2,942,000 shares. The transaction is expected to raise about US$25,000,000 in gross proceeds. See our latest analysis for Momentus. The private placement and recent shelf registrations have arrived after a sharp swing in sentiment, with the 30 day share price return of 278.91% and year to date share price return of 237.98% contrasting with a...
NYSE:FPS
NYSE:FPSElectrical

Is It Too Late To Consider Forgent Power Solutions (FPS) After A 64% Year To Date Jump?

Wondering if Forgent Power Solutions at around US$47.56 is offering value or stretching expectations? This article walks through what the current price might be telling you. The stock has eased about 2% over the past week, but is still up 28.9% over the past month and 64.0% year to date, which can change how you think about both upside and risk. Recent coverage has focused on Forgent Power Solutions as investors look more closely at power and grid related companies, with attention on how its...
NasdaqGS:FIZZ
NasdaqGS:FIZZBeverage

Assessing National Beverage (FIZZ) Valuation After Recent Share Price Momentum

Why National Beverage stock is drawing attention National Beverage (FIZZ) is back on investors’ radar after a recent share price move, with returns over the past month and past 3 months prompting closer scrutiny of its fundamentals and valuation. See our latest analysis for National Beverage. At a recent share price of US$37.24, the stock has a 1 month share price return of 7.91% and a year to date share price return of 17.62%, yet the 1 year total shareholder return is down 16.95%. This...
NYSE:VMC
NYSE:VMCBasic Materials

Is Vulcan Materials (VMC) Share Price Outrunning Its Cash Flow And Earnings Outlook

Wondering if Vulcan Materials at a recent US$276.75 close is priced appropriately for its future or offering limited value? This article walks through what the numbers actually say about the stock. Recent returns have been mixed, with the stock up 5.6% over the past week, down 5.0% over the past month, down 5.4% year to date, and up 5.1% over the past year, which can signal changing views on both opportunity and risk. Recent news flow around Vulcan Materials has centered on ongoing interest...
NasdaqCM:GSM
NasdaqCM:GSMMetals and Mining

Exploring Undervalued Small Caps With Insider Action In May 2026

The United States market has shown robust performance recently, climbing 1.8% in the last seven days and rising 28% over the past year, with earnings forecasted to grow by 17% annually. In this thriving environment, identifying small-cap stocks that are potentially undervalued and experiencing insider action can present unique opportunities for investors seeking to capitalize on growth prospects within emerging companies.
NasdaqGM:EYPT
NasdaqGM:EYPTPharmaceuticals

Can EyePoint (EYPT) Turn DURAVYU’s Six‑Month Dosing Goal Into Lasting Competitive Advantage?

EyePoint Pharmaceuticals recently presented at the Stifel 2026 Virtual Ophthalmology Forum and reiterated that top-line Phase 3 data for its wet age-related macular degeneration (AMD) therapy DURAVYU are expected to begin reading out in August, with a second pivotal trial to follow about two months later. Management highlighted 2026 as potentially transformative, emphasizing ambitions for DURAVYU to match a leading therapy on vision outcomes while maintaining safety and reducing treatment...
NasdaqGM:LNTH
NasdaqGM:LNTHMedical Equipment

Lantheus ASCO Data To Test Radiopharma Pipeline And Valuation Gap Narrative

Lantheus Holdings (NasdaqGM:LNTH) plans to present new clinical data for LNTH-2403, an LRRC15-targeted radiopharmaceutical, at the 2026 ASCO Annual Meeting. The company will also share real-world data on piflufolastat F 18 imaging use in early-stage prostate cancer at the same conference. These updates provide fresh detail on both Lantheus's osteosarcoma pipeline and the adoption of its approved prostate cancer imaging agent. Lantheus focuses on radiopharmaceuticals and imaging agents used...
NasdaqGS:WDAY
NasdaqGS:WDAYSoftware

Exploring 3 High Growth Tech Stocks In The US Market

Over the last 7 days, the United States market has risen 1.8% and in the past year, it has climbed 28%, with earnings expected to grow by 17% per annum over the next few years. In this environment, identifying high growth tech stocks involves looking at companies that not only show strong potential for revenue expansion but also align well with these positive market trends.
NYSE:COF
NYSE:COFConsumer Finance

Capital One’s Discover Integration Puts Valuation And Execution In Focus

Capital One Financial (NYSE:COF) is moving Discover’s credit card portfolio onto Capital One’s own back-office platform as part of the merger process. The integration focuses on consolidating technology systems and operational processes used to service and process Discover credit card accounts. The back-office migration is expected to influence cost efficiency, revenue opportunities, and how the combined company competes in card processing. For you as an investor, this move sits at the...
NYSE:PCOR
NYSE:PCORSoftware

Discover May 2026's Stocks That Could Be Trading Below Estimated Value

The United States market has shown robust performance, rising 1.8% over the last week and climbing 28% in the past year, with earnings projected to grow by 17% annually. In this thriving environment, identifying stocks that are trading below their estimated value can offer potential opportunities for investors looking to capitalize on market growth while minimizing risk.
NasdaqGS:CMPS
NasdaqGS:CMPSBiotechs

New Board Appointment At COMPASS Pathways And What It Means For Investors

COMPASS Pathways (NasdaqGS:CMPS) has appointed Kathleen Tregoning to its Board of Directors. Tregoning brings extensive biotech and pharmaceutical leadership experience, including roles at Cerevel Therapeutics and other large drugmakers. The appointment is intended to support COMPASS Pathways as it advances late stage programs and prepares for potential commercialization. For investors tracking mental health treatment companies, COMPASS Pathways focuses on developing therapies for...
NYSE:NOV
NYSE:NOVEnergy Services

Assessing NOV (NOV) Valuation After New Regular And Supplemental Dividend Declarations

NOV Inc. (NOV) has drawn fresh attention after its board declared a regular quarterly cash dividend of $0.09 per share, as well as a supplemental $0.09 dividend under its 2025 return of capital plan. See our latest analysis for NOV. The stock has shown firm longer term momentum, with a year to date share price return of 23.46% and a 1 year total shareholder return of 71.44%. However, the 7 day share price return declined 2.88% as the market absorbed these dividend announcements. If this kind...
NasdaqGS:API
NasdaqGS:APISoftware

High Insider Stakes In Leading Growth Companies May 2026

The United States market has shown robust performance, climbing 1.8% in the last 7 days and up 28% over the past year, with earnings forecasted to grow by 17% annually. In this thriving environment, growth companies with high insider ownership can be particularly compelling as they often signal confidence from those who know the company best.
NasdaqGS:GPRO
NasdaqGS:GPROConsumer Durables

Penny Stocks To Watch In May 2026

The market is up 1.8% over the last week and has climbed 28% over the past year, with earnings forecast to grow by 17% annually. Though the term 'penny stock' might sound like a relic of past trading days, these smaller or newer companies can still offer significant opportunities when built on solid financials. We've selected three examples of penny stocks that combine balance sheet strength with potential for outsized gains, giving investors a chance to discover hidden value in quality...
NasdaqGS:WING
NasdaqGS:WINGHospitality

Wingstop (WING) Rebound Raises Fresh Questions Around Its Current Valuation

If you are wondering whether Wingstop at around US$157.61 is priced attractively or asking too much for its growth story, you are not alone. The stock has jumped 18.8% over the past week, yet it is still down 8.9% over the past month, 38.6% year to date, and 53.4% over the last year, which may signal that expectations and risk perceptions have shifted quickly. These moves sit against a backdrop of ongoing expansion of the Wingstop brand and continued investor attention on restaurant stocks...
NasdaqCM:AENT
NasdaqCM:AENTRetail Distributors

Discover 3 Undiscovered Gems in the US Market

The United States market has experienced a notable rise, climbing 1.8% in the last week and up 28% over the past year, with earnings projected to grow by 17% annually. In such a robust environment, identifying stocks that combine strong fundamentals with growth potential can uncover promising opportunities for investors seeking to capitalize on these favorable conditions.
NasdaqCM:CZFS
NasdaqCM:CZFSBanks

3 Leading Dividend Stocks With Yields Up To 4.6%

Over the last 7 days, the United States market has risen by 1.8%, and over the past 12 months, it has seen a significant increase of 28%, with earnings projected to grow by 17% annually in the coming years. In such a robust market environment, identifying dividend stocks with strong yields can be an effective strategy for investors seeking consistent income and potential growth.